{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:07:23Z","timestamp":1791360443841,"version":"4.3.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002345"],"award-info":[{"award-number":["UL1TR002345"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1TR002344"],"award-info":[{"award-number":["TL1TR002344"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10549-020-05768-2","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T19:02:36Z","timestamp":1594407756000},"page":"251-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR\u2009+\u2009breast cancer and negative axillary ultrasound"],"prefix":"10.1007","volume":"183","author":[{"given":"Aubriana M.","family":"McEvoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Poplack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelin","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foluso","family":"Ademuyiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Zoberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Odom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hsin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0465-3071","authenticated-orcid":false,"given":"William E.","family":"Gillanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"issue":"10","key":"5768_CR1","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L et al (2017) Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA 318(10):918\u2013926","journal-title":"JAMA"},{"issue":"8","key":"5768_CR2","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1200\/JCO.1993.11.8.1536","volume":"11","author":"PP Lin","year":"1993","unstructured":"Lin PP, Allison DC, Wainstock J et al (1993) Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 11(8):1536\u20131544","journal-title":"J Clin Oncol"},{"issue":"1","key":"5768_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cct.2012.09.003","volume":"34","author":"SD Ramsey","year":"2013","unstructured":"Ramsey SD, Barlow WE, Gonzalez-Angulo AM et al (2013) Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes. Contemp Clin Trials 34(1):1\u20139","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"5768_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","volume":"379","author":"JA Sparano","year":"2018","unstructured":"Sparano JA, Gray RJ, Makower DF et al (2018) Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer. N Engl J Med 379(2):111\u2013121","journal-title":"N Engl J Med"},{"issue":"5","key":"5768_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2217\/14796694.4.5.603","volume":"4","author":"JA Zujewski","year":"2008","unstructured":"Zujewski JA, Kamin L (2008) Trial assessing individualized options for treatment for breast cancer: the TAILORx trial. Future Oncol 4(5):603\u2013610","journal-title":"Future Oncol"},{"issue":"1","key":"5768_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","volume":"11","author":"KS Albain","year":"2010","unstructured":"Albain KS, Barlow WE, Shak S et al (2010) Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol 11(1):55\u201365","journal-title":"Lancet Oncol"},{"issue":"27","key":"5768_CR7","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27):2817\u20132826","journal-title":"N Engl J Med"},{"key":"5768_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41523-017-0033-7","volume":"3","author":"SM Stemmer","year":"2017","unstructured":"Stemmer SM, Steiner M, Rizel S et al (2017) Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry. NPJ Breast Cancer 3:32","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"5768_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s10549-017-4358-6","volume":"165","author":"U Nitz","year":"2017","unstructured":"Nitz U, Gluz O, Christgen M et al (2017) Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial. Breast Cancer Res Treat 165(3):573\u2013583","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"5768_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98(9):599\u2013609","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5768_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jso.21535","volume":"102","author":"T Ashikaga","year":"2010","unstructured":"Ashikaga T, Krag DN, Land SR et al (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102(2):111\u2013118","journal-title":"J Surg Oncol"},{"issue":"3","key":"5768_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/01.sla.0000245472.47748.ec","volume":"245","author":"I Langer","year":"2007","unstructured":"Langer I, Guller U, Berclaz G et al (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245(3):452\u2013461","journal-title":"Ann Surg"},{"issue":"8","key":"5768_CR13","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/annonc\/mdp016","volume":"20","author":"TS Dabakuyo","year":"2009","unstructured":"Dabakuyo TS, Fraisse J, Causeret S et al (2009) A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection. Ann Oncol 20(8):1352\u20131361","journal-title":"Ann Oncol"},{"issue":"13","key":"5768_CR14","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1001\/jama.2013.277804","volume":"310","author":"R Rao","year":"2013","unstructured":"Rao R, Euhus D, Mayo HG et al (2013) Axillary node interventions in breast cancer: a systematic review. JAMA 310(13):1385\u20131394","journal-title":"JAMA"},{"issue":"32","key":"5768_CR15","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","volume":"26","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Wright MJ, Morris KT et al (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26(32):5213\u20135219","journal-title":"J Clin Oncol"},{"issue":"12","key":"5768_CR16","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1200\/JCO.2008.18.3517","volume":"27","author":"YC Shih","year":"2009","unstructured":"Shih YC, Xu Y, Cormier JN et al (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27(12):2007\u20132014","journal-title":"J Clin Oncol"},{"issue":"2","key":"5768_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000360411","volume":"9","author":"T Reimer","year":"2014","unstructured":"Reimer T, Hartmann S, Stachs A et al (2014) Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trial. Breast Care (Basel) 9(2):87\u201395","journal-title":"Breast Care (Basel)"},{"issue":"6","key":"5768_CR18","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1245\/s10434-018-6410-0","volume":"25","author":"BK Killelea","year":"2018","unstructured":"Killelea BK, Long JB, Dang W et al (2018) Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ. Ann Surg Oncol 25(6):1521\u20131529","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"5768_CR19","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1245\/s10434-010-1155-4","volume":"17","author":"JI Goldberg","year":"2010","unstructured":"Goldberg JI, Wiechmann LI, Riedel ER et al (2010) Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema. Ann Surg Oncol 17(12):3278\u20133286","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"5768_CR20","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.suronc.2010.10.002","volume":"20","author":"C Bezu","year":"2011","unstructured":"Bezu C, Coutant C, Salengro A et al (2011) Anaphylactic response to blue dye during sentinel lymph node biopsy. Surg Oncol 20(1):e55\u2013e59","journal-title":"Surg Oncol"},{"issue":"2","key":"5768_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/SLA.0b013e31821f1564","volume":"254","author":"N Houssami","year":"2011","unstructured":"Houssami N, Ciatto S, Turner RM et al (2011) Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg 254(2):243\u2013251","journal-title":"Ann Surg"},{"issue":"4","key":"5768_CR22","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.surg.2013.07.017","volume":"154","author":"TJ Hieken","year":"2013","unstructured":"Hieken TJ, Trull BC, Boughey JC et al (2013) Preoperative axillary imaging with percutaneous lymph node biopsy is valuable in the contemporary management of patients with breast cancer. Surgery 154(4):831\u2013838","journal-title":"Surgery"},{"issue":"5","key":"5768_CR23","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.2214\/AJR.05.0936","volume":"186","author":"S Alvarez","year":"2006","unstructured":"Alvarez S, Anorbe E, Alcorta P et al (2006) Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol 186(5):1342\u20131348","journal-title":"AJR Am J Roentgenol"},{"key":"5768_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejrad.2017.11.018","volume":"98","author":"J Del Riego","year":"2018","unstructured":"Del Riego J, Diaz-Ruiz MJ, Teixido M et al (2018) The impact of axillary ultrasound with biopsy in overtreatment of early breast cancer. Eur J Radiol 98:158\u2013164","journal-title":"Eur J Radiol"},{"issue":"11","key":"5768_CR25","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1245\/s10434-014-3813-4","volume":"21","author":"AS Caudle","year":"2014","unstructured":"Caudle AS, Kuerer HM, Le-Petross HT et al (2014) Predicting the extent of nodal disease in early-stage breast cancer. Ann Surg Oncol 21(11):3440\u20133447","journal-title":"Ann Surg Oncol"},{"key":"5768_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.breast.2016.09.009","volume":"30","author":"M Gipponi","year":"2016","unstructured":"Gipponi M, Fregatti P, Garlaschi A et al (2016) Axillary ultrasound and Fine-Needle Aspiration Cytology in the preoperative staging of axillary node metastasis in breast cancer patients. Breast 30:146\u2013150","journal-title":"Breast"},{"issue":"6","key":"5768_CR27","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/SLA.0000000000001549","volume":"264","author":"NS Tucker","year":"2016","unstructured":"Tucker NS, Cyr AE, Ademuyiwa FO et al (2016) Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer. Ann Surg 264(6):1098\u20131102","journal-title":"Ann Surg"},{"issue":"2","key":"5768_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1055\/s-0042-122853","volume":"77","author":"T Reimer","year":"2017","unstructured":"Reimer T, Stachs A, Nekljudova V et al (2017) Restricted Axillary Staging in Clinically and Sonographically Node-Negative Early Invasive Breast Cancer (c\/iT1-2) in the Context of Breast Conserving Therapy: First Results Following Commencement of the Intergroup-Sentinel-Mamma (INSEMA) Trial. Geburtshilfe Frauenheilkd 77(2):149\u2013157","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"6","key":"5768_CR29","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/bjc.2012.62","volume":"106","author":"H Verry","year":"2012","unstructured":"Verry H, Lord SJ, Martin A et al (2012) Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis. Br J Cancer 106(6):1045\u20131052","journal-title":"Br J Cancer"},{"issue":"4","key":"5768_CR30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jamcollsurg.2014.12.033","volume":"220","author":"R Henry-Tillman","year":"2015","unstructured":"Henry-Tillman R, Glover-Collins K, Preston M et al (2015) The SAVE review: sonographic analysis versus excision for axillary staging in breast cancer. J Am Coll Surg 220(4):560\u2013567","journal-title":"J Am Coll Surg"},{"key":"5768_CR31","doi-asserted-by":"crossref","unstructured":"Dean LT, Moss SL, Ransome Y, et al. \"It still affects our economic situation\": long-term economic burden of breast cancer and lymphedema. Support Care Cancer 2018.","DOI":"10.1007\/s00520-018-4418-4"},{"issue":"5","key":"5768_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","volume":"21","author":"O Gentilini","year":"2012","unstructured":"Gentilini O, Veronesi U (2012) Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). Breast 21(5):678\u2013681","journal-title":"Breast"},{"issue":"4","key":"5768_CR33","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1245\/s10434-010-0919-1","volume":"17","author":"JC Boughey","year":"2010","unstructured":"Boughey JC, Moriarty JP, Degnim AC et al (2010) Cost modeling of preoperative axillary ultrasound and fine-needle aspiration to guide surgery for invasive breast cancer. Ann Surg Oncol 17(4):953\u2013958","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"5768_CR34","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1200\/JCO.2009.24.9284","volume":"28","author":"KD Voduc","year":"2010","unstructured":"Voduc KD, Cheang MC, Tyldesley S et al (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28(10):1684\u20131691","journal-title":"J Clin Oncol"},{"key":"5768_CR35","unstructured":"SEER*Stat Database: Incidence - SEER 18 Regs Research Data. In Surveillance E, and End Results (SEER) Program, ed. www.seer.cancer.gov, 1975\u20132016."},{"key":"5768_CR36","doi-asserted-by":"crossref","unstructured":"Howlader N, Altekruse SF, Li CI, et al. (2014) US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 106(5).","DOI":"10.1093\/jnci\/dju055"},{"key":"5768_CR37","unstructured":"Amin MB, Edge SB, American Joint Committee on Cancer. AJCC cancer staging manual. Eighth edition. ed. Switzerland: Springer, 2017."},{"key":"5768_CR38","unstructured":"(NCCN) NCCN. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. 2019(Version 1.2019)."},{"key":"5768_CR39","doi-asserted-by":"crossref","unstructured":"Hunink MGM. Decision making in health and medicine : integrating evidence and values. Second edition. ed. Cambridge, United Kingdom: Cambridge University Press, 2014.","DOI":"10.1017\/CBO9781139506779"},{"key":"5768_CR40","unstructured":"Mcevoy AM CS, Gillanders W, Poplack SP. Systematic Review and Meta-Analysis: Diagnostic accuracy and clinical utility of axillary ultrasound in invasive breast cancer. PROSPERO 2019."},{"issue":"19","key":"5768_CR41","first-page":"1878","volume":"373","author":"TJ Whelan","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Levine MN (2015) Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med 373(19):1878\u20131879","journal-title":"N Engl J Med"},{"issue":"9935","key":"5768_CR42","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"McGale P, Taylor C, Correa C et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383(9935):2127\u20132135","journal-title":"Lancet"},{"key":"5768_CR43","unstructured":"Consumer Price Index Summary 2019. Available at: www.bls.gov\/cpi. 2019."},{"issue":"15","key":"5768_CR44","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","volume":"276","author":"MC Weinstein","year":"1996","unstructured":"Weinstein MC, Siegel JE, Gold MR et al (1996) Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 276(15):1253\u20131258","journal-title":"JAMA"},{"issue":"5","key":"5768_CR45","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/j.1523-1755.2004.00950.x","volume":"66","author":"PA McFarlane","year":"2004","unstructured":"McFarlane PA, Bayoumi AM (2004) Acceptance and rejection: cost-effectiveness and the working nephrologist. Kidney Int 66(5):1735\u20131741","journal-title":"Kidney Int"},{"key":"5768_CR46","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1016\/j.ejim.2017.05.015","volume":"43","author":"S Trippoli","year":"2017","unstructured":"Trippoli S (2017) Incremental cost-effectiveness ratio and net monetary benefit: Current use in pharmacoeconomics and future perspectives. Eur J Intern Med 43:e36","journal-title":"Eur J Intern Med"},{"issue":"2","key":"5768_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2471\/BLT.14.138206","volume":"93","author":"E Marseille","year":"2015","unstructured":"Marseille E, Larson B, Kazi DS et al (2015) Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ 93(2):118\u2013124","journal-title":"Bull World Health Organ"},{"key":"5768_CR48","volume-title":"A systematic review of axillary ultrasound for regional staging of invasive breast cancer: assessing exam performance by nodal burden, imaging criteria, and tumor characteristics","author":"AMCS Mcevoy","year":"2019","unstructured":"Mcevoy AMCS, Gillanders W, Poplack SP (2019) A systematic review of axillary ultrasound for regional staging of invasive breast cancer: assessing exam performance by nodal burden, imaging criteria, and tumor characteristics. Washington University, St. Louis"},{"issue":"18","key":"5768_CR49","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1200\/JCO.2011.38.5740","volume":"30","author":"MJ Hassett","year":"2012","unstructured":"Hassett MJ, Silver SM, Hughes ME et al (2012) Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol 30(18):2218\u20132226","journal-title":"J Clin Oncol"},{"issue":"5","key":"5768_CR50","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/S0360-3016(97)00555-5","volume":"39","author":"FA Vicini","year":"1997","unstructured":"Vicini FA, Horwitz EM, Lacerna MD et al (1997) The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 39(5):1069\u20131076","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5768_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/jrr\/rrw071","volume":"58","author":"K Hirata","year":"2017","unstructured":"Hirata K, Yoshimura M, Inoue M et al (2017) Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation. J Radiat Res 58(1):79\u201385","journal-title":"J Radiat Res"},{"issue":"8","key":"5768_CR52","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","volume":"26","author":"AS Coates","year":"2015","unstructured":"Coates AS, Winer EP, Goldhirsch A et al (2015) Tailoring therapies\u2013improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol 26(8):1533\u20131546","journal-title":"Ann Oncol"},{"issue":"8","key":"5768_CR53","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong JH, Anderson S et al (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347(8):567\u2013575","journal-title":"N Engl J Med"},{"issue":"28","key":"5768_CR54","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1200\/JCO.2012.48.1903","volume":"31","author":"T Hsu","year":"2013","unstructured":"Hsu T, Ennis M, Hood N et al (2013) Quality of life in long-term breast cancer survivors. J Clin Oncol 31(28):3540\u20133548","journal-title":"J Clin Oncol"},{"issue":"3","key":"5768_CR55","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.critrevonc.2014.06.004","volume":"92","author":"NR Taghian","year":"2014","unstructured":"Taghian NR, Miller CL, Jammallo LS et al (2014) Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hematol 92(3):227\u2013234","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"5768_CR56","first-page":"23","volume":"9","author":"H Blumen","year":"2016","unstructured":"Blumen H, Fitch K, Polkus V (2016) Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service. Am Health Drug Benefits 9(1):23\u201332","journal-title":"Am Health Drug Benefits"},{"issue":"1","key":"5768_CR57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/archsurg.2007.11","volume":"143","author":"MA Olsen","year":"2008","unstructured":"Olsen MA, Chu-Ongsakul S, Brandt KE et al (2008) Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg 143(1):53\u201360","journal-title":"Arch Surg"},{"key":"5768_CR58","unstructured":"Mcevoy AM CS, Nickel K, Olsen MA, Gillanders W, Poplack SP. MarketScan\u00ae Commercial Database. In IBM, ed.: Center for Administrative Data Research, 2019."},{"issue":"4","key":"5768_CR59","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/annonc\/mdp386","volume":"21","author":"E Botteri","year":"2010","unstructured":"Botteri E, Bagnardi V, Rotmensz N et al (2010) Analysis of local and regional recurrences in breast cancer after conservative surgery. Ann Oncol 21(4):723\u2013728","journal-title":"Ann Oncol"},{"issue":"3","key":"5768_CR60","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10549-017-4340-3","volume":"165","author":"YM Geurts","year":"2017","unstructured":"Geurts YM, Witteveen A, Bretveld R et al (2017) Patterns and predictors of first and subsequent recurrence in women with early breast cancer. Breast Cancer Res Treat 165(3):709\u2013720","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"5768_CR61","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/cncr.11767","volume":"98","author":"EE Harris","year":"2003","unstructured":"Harris EE, Hwang WT, Seyednejad F et al (2003) Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy. Cancer 98(10):2144\u20132151","journal-title":"Cancer"},{"issue":"2","key":"5768_CR62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.radonc.2006.04.006","volume":"79","author":"HM Nielsen","year":"2006","unstructured":"Nielsen HM, Overgaard M, Grau C et al (2006) Loco-regional recurrence after mastectomy in high-risk breast cancer-risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. Radiother Oncol 79(2):147\u2013155","journal-title":"Radiother Oncol"},{"issue":"2","key":"5768_CR63","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10549-011-1594-z","volume":"130","author":"T Foukakis","year":"2011","unstructured":"Foukakis T, Fornander T, Lekberg T et al (2011) Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm. Sweden Breast Cancer Res Treat 130(2):553\u2013560","journal-title":"Sweden Breast Cancer Res Treat"},{"issue":"12","key":"5768_CR64","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1525-1497.2006.00609.x","volume":"21","author":"MD Schleinitz","year":"2006","unstructured":"Schleinitz MD, DePalo D, Blume J et al (2006) Can differences in breast cancer utilities explain disparities in breast cancer care? J Gen Intern Med 21(12):1253\u20131260","journal-title":"J Gen Intern Med"},{"key":"5768_CR65","unstructured":"Administration SS. Actuarial Life Table 2016. Available at: https:\/\/www.ssa.gov\/oact\/STATS\/table4c6.html. 2019."},{"issue":"19","key":"5768_CR66","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, Gray R, Braybrooke J et al (2017) 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years. N Engl J Med 377(19):1836\u20131846","journal-title":"N Engl J Med"},{"issue":"2","key":"5768_CR67","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ijc.31914","volume":"144","author":"MC van Maaren","year":"2019","unstructured":"van Maaren MC, de Munck L, Strobbe LJA et al (2019) Ten-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study. Int J Cancer 144(2):263\u2013272","journal-title":"Int J Cancer"},{"issue":"2","key":"5768_CR68","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1524-4733.2007.00226.x","volume":"11","author":"ME Stokes","year":"2008","unstructured":"Stokes ME, Thompson D, Montoya EL et al (2008) Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data. Value Health 11(2):213\u2013220","journal-title":"Value Health"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05768-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05768-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05768-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T19:11:08Z","timestamp":1650222668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05768-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5768"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05768-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"assertion":[{"value":"29 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors (Aubriana McEvoy, Steven Poplack, Katelin Nickel, Margaret Olsen, Foluso Ademuyiwa, Imran Zoberi, Elizabeth Odom, Jennifer Yu, Su-Hsin Chang, and William Gillanders) have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}